New Vitamin A Derivatives Show Early Cancer Promise
NIH researchers report two dozen new vitamin A derivatives in the retinylidene-1,3-diketone class showing preliminary anti-cancer activity in lab and animal studies. Some compounds appear less toxic and better tolerated with long-term use, though human testing is pending.